Recent advances in precision medicine for pancreatic ductal adenocarcinoma
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Although advances in systemic chemotherapy for PDAC have improved survival outcomes for patients with the disease, chemoresistance is a major treatment issue for unselected PDAC patient populations. The existence of heterogeneity caused by a mixture...
Alternative Titles
Full title
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a1a42ad0369645b5bfe151067665e2b8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1a42ad0369645b5bfe151067665e2b8
Other Identifiers
ISSN
2475-0328
E-ISSN
2475-0328
DOI
10.1002/ags3.12436
